Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
12.95M
Cash
2.833M
Avg Qtr Burn
-1.39M
Short % of Float
4.89%
Insider Ownership
23.33%
Institutional Own.
6.51%
Qtr Updated
12/31/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Ketamir-2 Details Neuropathic pain | Phase 1 Data readout |